Unlocking voice as a predictive biomarker using AI to detect diseases and support digital diagnostics and therapies across Longevity and neurodegeneration.
Funding, launches and regulatory moves across the neurotech startup map.
Subscribed. Check your inbox to confirm.
•
Neurofounders Insights
$ Funding -
Defunct
MODALITY
Biomarkers
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Multi-indication
TARGET USER
Pharma
REGULATORY STAGE
Investigational
EVOCAL Health operates in the voice biomarker space, targeting longevity and neurodegeneration through speech analysis. Its positioning overlaps with multiple competitors, with differentiation dependent on dataset quality and partnerships.
.svg)
